Menu
Close
Sign up for NPL updates
Close
Sign up for NPL updates

Receive regular emails from NPL to get a glimpse of our activities and see how our experts are informing and influencing scientific debate

Giuseppe Schettino

Giuseppe Schettino

Principal scientist

Giuseppe Schettino is a Principal Scientist in the Medical Radiation Science Group at the NPL. He graduated in Nuclear Physics at the University of Naples (Italy) in 1994 and obtained his PhD from King's College London (UK) in 1999, working on the development of ultrasoft X-ray microbeams for radiobiological applications. Following two postdoctoral experiences at the Gray Cancer Institute in the UK (2000-2004) and Center for Radiological Research at the Columbia University in New York (2004-2007), he worked as Lecturer at the Centre for Cancer Research and Cell Biology (CCRCB) of Queen's University Belfast from 2007 to 2013. In 2013, Giuseppe joined the Medical Radiation Physics Group at NPL as Principal Research Scientist with a joint position as Professor in Medical Physics at the University of Surrey (2018-2023). Giuseppe is Chartered Physicist (CPhys) and Fellow (FInstP) at the Institute of Physics (IoP), Fellow of the Institute of Physics and Engineering in Medicine (IPEM) and Honorary Member of the Royal College of Radiologists (RCR). He holds visiting positions at the Queen's University Belfast and the University College London and has supervised 15 PhD students to completion. Giuseppe is also Editorial Board Member of Cancer Nanotechnology and member of several Radiation Research organisations.

Current interests

Giuseppe's main research interest is in radiation biology, advanced radiotherapy and dosimetry. His current ongoing research activities are focused on the biological effectiveness of proton and ion beams, micro-dosimetry, dosimetry and radiobiology for FLASH exposures, use of gold nanoparticle as radio-sensitisers, definition of new dosimetry quantities closely related to biological response and biological optimisation of treatment plans. He is also leading UK initiatives for standardisation of dosimetry and QA processes for pre-clinical radiotherapy and radiobiology research. To date, he has published over 100 peer-reviewed papers (h-index 35) and two book chapters.

Google scholar

LinkedIn

ResearchGate